# Implant for Augmentation of Cerebral Blood Flow Trial, Effectiveness and Safety in a 24 Hour Window (ImpACT-24A)

> **NCT03767192** · NA · TERMINATED · sponsor: **BrainsGate** · enrollment: 327 (actual)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DEVICE:** Active Stimulation
- **DEVICE:** Sham Stimulation

## Key facts

- **NCT ID:** NCT03767192
- **Lead sponsor:** BrainsGate
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-01
- **Primary completion:** 2011-01
- **Final completion:** 2012-03
- **Target enrollment:** 327 (ACTUAL)
- **Why stopped:** Protocol Amendment
- **Last updated:** 2019-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03767192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03767192, "Implant for Augmentation of Cerebral Blood Flow Trial, Effectiveness and Safety in a 24 Hour Window (ImpACT-24A)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03767192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*